Skip to content
10-Q

Quarterly Report

MJ BIOTECH, INC.

0001543272-18-000055

← back to feed
Filed
Nov 19, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 15, 2018 53.35M sh
Shares Outstanding Q3 2018 · Sep 30, 2018 53.35M sh
Shares Diluted Q3 2018 · Sep 30, 2018 724.39M sh
Shares Diluted Q3 2018 · Sep 30, 2018 47.61M sh
Shares Diluted restated Q3 2018 · Sep 30, 2017 562.18M sh
Shares Diluted Q3 2018 · Sep 30, 2017 24.76M sh
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$33.31K
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$157.32K
Cash And Equivalents Q3 2018 · Sep 30, 2018 $0
Cash And Equivalents Q3 2018 · Dec 31, 2017 $82
Cash And Equivalents Q3 2018 · Sep 30, 2017 $0
Cash And Equivalents Q3 2018 · Dec 31, 2016 $26.77K
Stockholders Equity Q3 2018 · Sep 30, 2018 −$2.5M
Stockholders Equity Q3 2018 · Dec 31, 2017 −$1.8M
Current Liabilities Q3 2018 · Sep 30, 2018 $2.5M
Current Liabilities Q3 2018 · Dec 31, 2017 $1.8M
Total Liabilities Q3 2018 · Sep 30, 2018 $2.5M
Total Liabilities Q3 2018 · Dec 31, 2017 $1.8M
Current Assets Q3 2018 · Sep 30, 2018 $0
Current Assets Q3 2018 · Dec 31, 2017 $82
Total Assets Q3 2018 · Sep 30, 2018 $0
Total Assets Q3 2018 · Dec 31, 2017 $82
Sga Expense Q3 2018 · Sep 30, 2018 $9.37K
Sga Expense Q3 2018 · Sep 30, 2018 $48.52K
Sga Expense Q3 2018 · Sep 30, 2017 $11.37K
Sga Expense restated Q3 2018 · Sep 30, 2017 $219.97K
Operating Income Q3 2018 · Sep 30, 2018 −$25.35K
Operating Income Q3 2018 · Sep 30, 2018 −$143.97K
Operating Income Q3 2018 · Sep 30, 2017 −$11.37K
Operating Income Q3 2018 · Sep 30, 2017 −$5.76M
Revenue Q3 2018 · Sep 30, 2018 $0
Revenue Q3 2018 · Sep 30, 2018 $0
Revenue Q3 2018 · Sep 30, 2017 $0
Revenue Q3 2018 · Sep 30, 2017 $0